MycoTechnology Funding, Investors & Competitors

MycoTechnology has raised $206M across 6 funding rounds, most recently a $85M Series E in March 2022.

Last MycoTechnology funding round

$85M

Series E · Mar 2022

Cumulative funding MycoTechnology raised

$206M

across 6 funding rounds

Key investors in MycoTechnology

  • S2G Investments
  • Bunge
  • Wavemaker Partners
  • Seventure Partners
  • Emerson Collective
  • GreatPoint Ventures
  • Evolution VC Partners
  • Middleland Capital

MycoTechnology Overview

About MycoTechnology

MycoTechnology is a fungi-based processing company incorporated in 2013 and based in Aurora, Colorado. The firm ferments agricultural products with gourmet mushroom strains to enhance flavors, launching ClearTaste as an organic bitter blocker certified Kosher and Halal for beverages and foods. MycoTechnology myceliates robusta and arabica coffee beans, chocolate, and other crops, licensing technology to roasters worldwide. Its platform addresses bitterness in stevia, coffee, and cacao, improving taste profiles without synthetic additives.


Founded

2013

HQ

United StatesChicago, IL

Website

mycoiq.com

Status

Privately held

Customer focus

B2B

Revenue model

Licensing

MycoTechnology Funding History

MycoTechnology has raised a total of $206M across 6 funding rounds.

MycoTechnology's first fundraising round was a $9M Series A in October 2015. The most recent completed round was a $85M Series E in March 2022.

MycoTechnology funding rounds

MycoTechnology funding rounds
DateStageInvestorsRaisedDeal Summary
Mar 2022Series EOman Investment Fund (lead)$85MMycoTechnology, founded in 2013 in Aurora, Colorado, develops a proprietary fermentation platform using mushroom mycelia to create innovative food ingredients, initially targeting alternative proteins and later shifting to flavors and sweeteners like Honey Truffle. The company raised $85 million in its Series E funding round on March 30, 2022, led by a group affiliated with the Oman Investment Authority (OIA), a sovereign wealth fund and first-time investor. New investors included Nourish Ventures (Griffith Foods’ VC arm), Rage Capital, Alphacy Investment, and Siddhi Capital, with returning participants such as S2G Ventures, Tyson Ventures, Continental Grain Company, Bunge Ventures, Maple Leaf Foods, Evolution VC Partners, and Gaingels. This brought total funding to over $200-220 million across rounds. The proceeds were earmarked to scale global operations, expand into Europe, Asia, and the Middle East, and advance the mycelia platform for food and nutrition applications, including plans for a facility in Oman to upcycle waste dates into mycelium proteins in partnership with OIA. Initially focused on mycelium-based meat alternatives, MycoTechnology pivoted amid challenging market conditions for alternative proteins, redirecting efforts to its flavor and sweetener portfolio. The company earned US GRAS approval for its Honey Truffle sweetener, planning North American commercialization in 2025-26 followed by other regions. MycoTechnology leverages fungi-based processing for sustainable ingredients, partnering with OIA for food security and sustainability initiatives in alternative proteins. The firm continues innovation, with CEO Alan Hahn highlighting the raise as validation for next-generation fungal ingredients.
Nov 2020Series DSyngenta Group (lead); Radicle Growth$1M-
Jun 2020Series DEvolution Capital Partners (lead); Evolution VC Partners (lead); Greenleaf Foods (lead); S2G Investments (lead)$39MMycoTechnology, a Colorado-based food tech company founded in 2013, develops a functional ingredients platform using mycelia, the root-like structures of mushrooms from over 60 fungi types, to create better-for-you products. Key offerings include ClearTaste, an organic bitter blocker that reduces sugar by masking bitterness in foods like coffee, and PureTaste, a sustainable shiitake mushroom-derived plant-based protein addressing global protein demands. The platform enables fermentation-driven solutions for off-flavor blocking, alternative proteins, and other innovations to improve taste without excess sugar, salt, or fat while enhancing sustainability. In June 2020, MycoTechnology raised $39 million in a Series D funding round co-led by Greenleaf Foods (owner of plant-based brands Lightlife and Field Roast), S2G Ventures (previously S2G Investments), Evolution VC Partners (also referred to as Evolution Partners), and SPC. Additional participants included Tyson Ventures, Kellogg’s Eighteen94 Capital, Bunge Ventures, Rich Products Ventures, Continental Grain, Middleland Capital, Seventure Partners, and Cibus Investments. This brought total funding to approximately $120-121 million across rounds, following a $30 million Series C. Prior Series A in 2015 ($9.2 million led by S2G) and Series C enabled ingredient innovation. CEO Alan Hahn noted the raise occurred without a valuation hit amid the pandemic, emphasizing the scalable platform's appeal. The funds supported R&D expansion, team growth, and commercialization of the fermentation platform for plant-based proteins and functional ingredients. Investors like Tyson Ventures highlighted MycoTechnology's novel mushroom fermentation for sustainable protein, aligning with demands for accessible global supply. At 92 employees, the company eyed an IPO in late 2022 to launch pipeline products and maintain mission control. The round positioned MycoTechnology as a highly valued food tech player, backed by Big Food giants amid rising alternative protein interest.
Jan 2019Series CCibus Capital (lead); Middleland MT Holdings (lead); S2G Investments (lead); TMI Investments BV (lead); Tyson Ventures; Continental Grain Company; Bunge; DNS-Hiitake; Eighteen94 Capital$30MMycoTechnology is a Colorado-based organic food technology company that has developed a novel mushroom fermentation platform to transform agricultural material into functional food ingredients. The company's flagship product, ClearTaste®, is marketed as the world's first organic bitter blocker that enables food companies to reduce sugar content by masking bitterness, while its second product, PureTaste®, is a sustainable, plant-based protein alternative designed to address food security challenges. The company closed a $30 million Series C financing round on January 30, 2019, with co-leads S2G Ventures Fund II, Middleland MT Holdings, ADM Capital's Cibus Fund, and TML-Invest S.à r.l., alongside participation from Tysons Ventures, Bunge Ventures Limited, Continental Grain Company, Kellogg's Eighteen94 Capital, and DNS-Hiitake. This round brought MycoTechnology's total cumulative funding to over $80 million, with sources indicating total funding reached $82.6 million across the investor syndicate that included Tao Capital, Closed Loop Capital, and Health for Life Capital. The capital was earmarked for expansion, acceleration of research and development projects, commercialization of new ingredients addressing food industry challenges including protein alternatives, sustainability, and salt reduction, and expansion of the company's team. CEO Alan Hahn announced post-closing that the company was planning an IPO tentatively for 2021.
Aug 2017Series BBunge (lead); Emerson Collective (lead); S2G Investments (lead)$42MMycoTechnology, based in Aurora, CO (noted as Boulder in some reports), develops fungi-based food-processing platforms using mycelium to create innovative ingredients like PureTaste, a vegan mushroom protein powder with 77-80% protein by dry weight, offering a slightly nutty taste without genetically engineered organisms. The company raised approximately $35-42 million in its Series B funding round in September-October 2017, led by S2G with co-leads Bunge Ventures and Emerson Collective, and additional investors including Closed Loop Capital, GreatPoint Ventures, Kinetic Ventures, Middleland Capital, Seventure Partners, Wavemaker Partners, Health For Life Capital, Tao Capital Partners, Eighteen94 Capital, Continental Grain, and Windy City LLC. The funds are earmarked for building a 4,000 metric ton per year commercial production facility in Aurora, Colorado, set to become operational in November 2018, enabling scale-up of PureTaste production. MycoTechnology is pursuing voluntary GRAS notification with the FDA, leveraging already GRAS components like pea, rice protein, and shiitake mushrooms.
Oct 2015Series AGreatPoint Ventures; Seventure Partners; S2G Investments; Wavemaker Partners; Middleland Capital; Closed Loop Capital$9MMycoTechnology raised $9.2 million in a Series A round in October 2015, led by S2G Ventures with participation from Seventure Partners and Middleland Capital, among others including Closed Loop Capital and GreatPoint Ventures. The company, founded in 2013 and based in Colorado, develops a food processing platform using mushroom roots (mycelium) in a process called 'myceliation' to remove unwanted compounds and infuse agricultural materials with beta glucans and digestible protein. This technology improves taste profiles, such as reducing bitterness in stevia, coffee, and chocolate, and enables gluten reduction in wheat. Prior to the Series A, MycoTechnology secured $6.7 million in a July 2015 investment round also led by S2G Ventures with Middleland Capital and Seventure Partners, aimed at expanding R&D, operations, sales, and technology adoption in food and beverage applications. The firm partnered with sweetener company U.S. Niutang to apply the MycoZyme process to its NiuVia stevia product. Subsequent rounds included a $42 million oversubscribed Series B in 2017 with investors like Emerson Collective, Continental Grain Company, and Health for Life Capital.

Who has invested in MycoTechnology?

21 investors have backed MycoTechnology across its funding rounds, including S2G Investments, Bunge, Wavemaker Partners, Seventure Partners, Emerson Collective and GreatPoint Ventures.

Lead investors include Oman Investment Fund, Syngenta Group, Evolution Capital Partners, Evolution VC Partners, Greenleaf Foods and 6 other investors.


MycoTechnology Investors

Investors in MycoTechnology by funding rounds participated
InvestorHQRoundsRoleFirst check
S2G InvestmentsUnited StatesChicago, IL4LeadOct 2015
BungeUnited StatesNew York City, NY2LeadAug 2017
Cibus CapitalUnited KingdomLondon1LeadJan 2019
Tyson VenturesUnited StatesSpringdale, AR1ParticipantJan 2019
Radicle GrowthUnited StatesSan Diego, CA1ParticipantNov 2020
GreatPoint VenturesUnited StatesNew Haven, CT1ParticipantOct 2015
Emerson CollectiveUnited StatesSan Francisco, CA1LeadAug 2017
Evolution VC PartnersUnited StatesNew York City, NY1LeadJun 2020
Syngenta GroupSwitzerlandSwitzerland1LeadNov 2020
Continental Grain CompanyUnited StatesNew York City, NY1ParticipantJan 2019
Oman Investment FundOmanMuscat1LeadMar 2022
Evolution Capital PartnersUnited StatesCleveland, OH1LeadJun 2020
DNS-HiitakeJapanJapan1ParticipantJan 2019

This data is available for Pro users. Sign up to see all 21 MycoTechnology investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

MycoTechnology Competitors

MycoTechnology competitors include listed companies like Hebei Yangyuan Zhihui and Ingredion, and private ones like Impossible Foods, Believer Meats, Eat Just and Oatside.

Public and private companies comparable to MycoTechnology
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Hebei Yangyuan ZhihuiChinaChinaPublicly listed$796M$254M$8.1B8.4x
Impossible FoodsUnited StatesSan Francisco, CAPrivate$460M-$7B15.2x
IngredionUnited StatesUnited StatesPublicly listed$7.2B$1.2B$6.2B1.0x
Believer MeatsIsraelJerusalemPrivate--$900M-
Eat JustUnited StatesSan Francisco, CAPrivate--$750M-
OatsideSingaporeSingaporePrivate$37M-$705M-

MycoTechnology Public Comps

MycoTechnology is still privately-owned, but its public comps include Coca-Cola, Nestlé, PepsiCo, AB InBev, Unilever, Monster Beverage, Mondelez, Nongfu Spring, Hindustan Unilever and Coca-Cola Europacific Partners.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Coca-Cola$48B$18B8.5x8.3x22.8x24.1x
Nestlé$109B$19B2.9x2.8x16.2x14.4x
PepsiCo$94B$16B2.4x2.3x14.5x11.8x
AB InBev$59B$20B3.9x3.6x11.7x10.0x
Unilever$58B$12B2.9x2.8x13.6x12.4x
Monster Beverage$8.3B$2.5B10.1x9.0x33.3x28.9x
Mondelez$39B$4.7B2.6x2.5x21.4x14.9x
Nongfu Spring$7.8B$3.5B6.9x6.3x15.2x14.0x

This data is available for Pro users. Sign up to see all MycoTechnology competitors and their valuation data.

Start Free Trial

Common questions about MycoTechnology

When was MycoTechnology founded?MycoTechnology was founded in 2013.
Where is MycoTechnology headquartered?MycoTechnology is headquartered in Chicago, IL, United States.
Is MycoTechnology publicly listed?No, MycoTechnology is a private, VC-backed company.
How much funding has MycoTechnology raised?MycoTechnology has raised $206M across 6 funding rounds.
What was MycoTechnology's last funding round?MycoTechnology's last funding round was a $85M Series E in March 2022, led by Oman Investment Fund.
Who are MycoTechnology's investors?MycoTechnology's investors include S2G Investments, Bunge, Cibus Capital, Tyson Ventures, Radicle Growth, GreatPoint Ventures, Emerson Collective, Evolution VC Partners, Syngenta Group, Continental Grain Company and 11 others.
Which companies are comparable to MycoTechnology?Companies comparable to MycoTechnology include Hebei Yangyuan Zhihui, Impossible Foods, Ingredion, Believer Meats, Eat Just and Oatside.

See companies similar to MycoTechnology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial